↓ Skip to main content

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Overview of attention for article published in Journal of Crohn's and Colitis Supplements, January 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

policy
3 policy sources
twitter
4 X users
patent
3 patents
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
1263 Dimensions

Readers on

mendeley
739 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
Published in
Journal of Crohn's and Colitis Supplements, January 2010
DOI 10.1016/j.crohns.2009.12.002
Pubmed ID
Authors

A. Dignass, G. Van Assche, J.O. Lindsay, M. Lémann, J. Söderholm, J.F. Colombel, S. Danese, A. D'Hoore, M. Gassull, F. Gomollón, D.W. Hommes, P. Michetti, C. O'Morain, T. Öresland, A. Windsor, E.F. Stange, S.P.L. Travis, for the European Crohn's and Colitis Organisation

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 739 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 7 <1%
Netherlands 4 <1%
United States 3 <1%
Italy 3 <1%
Argentina 2 <1%
Brazil 2 <1%
Spain 2 <1%
Israel 1 <1%
Norway 1 <1%
Other 4 <1%
Unknown 710 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 114 15%
Student > Master 90 12%
Other 89 12%
Student > Ph. D. Student 82 11%
Student > Bachelor 64 9%
Other 186 25%
Unknown 114 15%
Readers by discipline Count As %
Medicine and Dentistry 422 57%
Agricultural and Biological Sciences 46 6%
Biochemistry, Genetics and Molecular Biology 27 4%
Pharmacology, Toxicology and Pharmaceutical Science 27 4%
Nursing and Health Professions 20 3%
Other 62 8%
Unknown 135 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2023.
All research outputs
#1,881,732
of 26,017,215 outputs
Outputs from Journal of Crohn's and Colitis Supplements
#215
of 2,184 outputs
Outputs of similar age
#9,083
of 190,160 outputs
Outputs of similar age from Journal of Crohn's and Colitis Supplements
#1
of 13 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,184 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,160 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.